Zsírmáj (MASLD/MASH): nyitott vizsgálatok itt: Kanada
18 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Edmonton, Hamilton, Montreal, Terrebonne, Toronto, Vaughan
- Age
- 18 év to 80 év
- People
- 1650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Bridgewater, Calgary, Montreal, Québec, Terrebonne, Toronto, Vancouver
- Age
- 18 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444EU 2024-513739-25-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Bridgewater, Calgary, Montreal, Québec, Toronto, Vancouver
- Age
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457EU 2024-513741-36-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Calgary, London, Ottawa, Toronto, Vancouver, Vaughan, Winnipeg
- Age
- 18 év to 80 év
- People
- 1350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169EU 2023-509912-27-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Calgary, London, Ottawa, Toronto, Vancouver, Vaughan, Winnipeg
- Age
- 18 év to 75 év
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374EU 2023-510395-31-00Regiszter frissítve: 2026-10-23
2. fázisToborozTrial-stage medicine
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Where
- Edmonton
- Age
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07325526Regiszter frissítve: 2026-10-14
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Edmonton, Montreal, Terrebonne, Toronto, Vaughan
- Age
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314Regiszter frissítve: 2026-10-13
3. fázisToborozTrial-stage medicine
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Calgary, Chicoutimi, Edmonton, Halifax, London, North Bay, Québec, Toronto, Trois-Rivières, Vancouver, Winnipeg
- Age
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028EU 2025-522674-36-00Regiszter frissítve: 2026-10-08
No phaseToborozResearch participation
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
- Where
- Montreal
- Age
- 18 év and over
- People
- 102
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT03572465Regiszter frissítve: 2026-09-16
2. fázisToborozTrial-stage medicine
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
- Where
- Toronto
- Age
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- Madrigal Pharmaceuticals, Inc.
See details and how to joinNCT07335601Regiszter frissítve: 2026-08-26
4. fázisToborozTrial-stage medicine
Fibrosis Lessens After Metabolic Surgery
- Where
- Montreal
- Age
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875Regiszter frissítve: 2026-07-31
3. fázisToborozTrial-stage medicine
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- Where
- Québec
- Age
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07221227Regiszter frissítve: 2026-07-27
No phaseToborozTrial-stage medicine
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
- Where
- Sherbrooke
- Age
- 20 év to 80 év
- People
- 36
- Run by
- Université de Sherbrooke
See details and how to joinNCT06843148Regiszter frissítve: 2026-07-02
No phaseToborozResearch participation
Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis
- Where
- London
- Age
- 18 év and over
- People
- 124
- Run by
- Anton Skaro
See details and how to joinNCT05884723Regiszter frissítve: 2026-05-19
1. fázisToborozTrial-stage medicine
A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
- Where
- Toronto
- Age
- 18 év to 64 év
- People
- 52
- Run by
- 1Globe Health Institute
See details and how to joinNCT06694935Regiszter frissítve: 2025-01-13
No phaseToborzás még nem indultTrial-stage medicine
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- Where
- Québec
- Age
- 18 év and over
- People
- 120
- Run by
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
See details and how to joinNCT06764056Regiszter frissítve: 2025-01-08
No phaseToborozResearch participation
Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD
- Where
- Québec
- Age
- 18 év to 75 év
- People
- 70
- Run by
- Valbiotis
See details and how to joinNCT06704321Regiszter frissítve: 2024-11-26
2. fázisToborozResearch participation
Soluble Fibre Supplementation in NAFLD
- Where
- Hamilton
- Age
- 8 év to 17 év
- People
- 60
- Run by
- McMaster University
See details and how to joinNCT05480696Regiszter frissítve: 2024-11-12
Minden vizsgálat (Zsírmáj (MASLD/MASH)) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.